Security Snapshot

Retension Pharmaceuticals, Inc. - Common Stock, $0.0001 par value Institutional Ownership

CUSIP: 76135H100

13F Institutional Holders and Ownership History

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
8,333,330
Filing notes and source

Key facts

  • 76135H100 - Retension Pharmaceuticals, Inc. - Common Stock, $0.0001 par value is tracked under CUSIP 76135H100.
  • Latest finished 13F holder period is not available.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Quarterly ownership records are not available yet for this CUSIP.
  • This page updates as SEC-backed holdings history becomes available.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

76135H100

Latest holder period

n/a

13F holders

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
76135H100
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PVG ASSET MANAGEMENT CORP 8.3% 1,002,050 PVG ASSET MANAGEMENT CORP 09 Oct 2026
B Group, Inc. 10% 833,333 The B Group, Inc. 13 Oct 2026
LYTTON LAURENCE W 7.4% 617,207 Laurence W. Lytton 13 Oct 2026
Keller Eric L. 7.1% 598,598 Eric Keller 13 Oct 2026
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .